[Hormone replacement therapy following breast carcinoma]. 1998

J G Klijn, and M Bontenbal
Academisch Zickenhuis Rotterdam-Daniel den Hoed Kliniek, afd. Interne Oncologie.

Additional advantages of hormone suppletion therapy (HST) in women with climacteric complaints are the reduced risks of development of cardiovascular disease and osteoporosis. A disadvantage is the enhanced risk of breast cancer. More and more women with a treated primary breast cancer nowadays have a relatively favourable prognosis; they might also profit by HST, especially if chemotherapy for breast cancer has led to an early menopause. Recent pilot studies of the connection between HST and recurrence of breast cancer are inadequate as to methodology and size to permit definite conclusions. There are numerous arguments for a connection between exposure to oestrogens and development of breast cancer. As long as it has not been demonstrated that HST does not lead to enhanced risk of breast cancer recurrence, the general recommendation should be not to administer HST to patients with treated breast carcinoma.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J G Klijn, and M Bontenbal
October 2000, Cancer,
J G Klijn, and M Bontenbal
June 1997, Ceska gynekologie,
J G Klijn, and M Bontenbal
October 1998, Schweizerische medizinische Wochenschrift,
J G Klijn, and M Bontenbal
June 1996, Current opinion in obstetrics & gynecology,
J G Klijn, and M Bontenbal
December 2002, Praxis,
J G Klijn, and M Bontenbal
March 2000, International journal of clinical practice,
J G Klijn, and M Bontenbal
May 2007, International journal of cancer,
J G Klijn, and M Bontenbal
November 2002, Ceska gynekologie,
J G Klijn, and M Bontenbal
February 1994, Hematology/oncology clinics of North America,
Copied contents to your clipboard!